Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Energy Select Sector SPDR | XLE | Sep 19, 2024 | 88.96 | +1.19 |
Energy Services of America | ESOA | Sep 19, 2024 | 10.38 | +3.80 |
Energy Transfer L.P | ET-I | Sep 19, 2024 | 12.06 | +3.17 |
Energy Transfer LP Unit | ET | Sep 19, 2024 | 16.17 | +0.37 |
Energy Transfer Pref E | ET-E | Sep 19, 2024 | 25.00 | 0.00 |
Energy Vault | NRGV | Sep 19, 2024 | 1.07 | +7.34 |
Enerpac Tool Group | EPAC | Sep 19, 2024 | 42.01 | +1.33 |
EnerSys | ENS | Sep 19, 2024 | 102.50 | +1.49 |
Enfusion | ENFN | Sep 19, 2024 | 8.55 | +1.54 |
Engene | ENGN | Sep 19, 2024 | 7.16 | -1.51 |
ENGlobal | ENG | Sep 19, 2024 | 1.43 | +14.40 |
Enhabit | EHAB | Sep 19, 2024 | 8.24 | +0.98 |
Enhanced Short-Maturity Strgy ETF Pimco | MINT | Sep 19, 2024 | 100.52 | +0.03 |
Eni ADR | E | Sep 19, 2024 | 32.06 | +1.20 |
Enlight Renewable Energy | ENLT | Sep 19, 2024 | 15.88 | +1.63 |
Enlink Midstream LLC Unit | ENLC | Sep 19, 2024 | 14.51 | +0.42 |
Enliven Therapeutics | ELVN | Sep 19, 2024 | 23.07 | +6.02 |
Enlivex Therapeutics | ENLV | Sep 19, 2024 | 1.50 | -3.23 |
Ennis | EBF | Sep 19, 2024 | 24.24 | +0.83 |
Enova International | ENVA | Sep 19, 2024 | 85.47 | +3.13 |
Enovis | ENOV | Sep 19, 2024 | 45.02 | +3.16 |
Enovix | ENVX | Sep 19, 2024 | 8.44 | -0.59 |
Enphase Energy | ENPH | Sep 19, 2024 | 117.36 | -1.99 |
Enphys Acquisition | NFYS | Sep 19, 2024 | 10.99 | 0.00 |
Enpro | NPO | Sep 19, 2024 | 162.36 | +3.57 |
Enservco | ENSV | Sep 19, 2024 | 0.12 | -5.04 |
Enstar Group | ESGR | Sep 19, 2024 | 321.10 | +0.70 |
Enstar Group Depository E Pref | ESGRO | Sep 19, 2024 | 20.22 | +0.35 |
Enstar Pref | ESGRP | Sep 19, 2024 | 19.23 | -0.36 |
Ensysce Biosciences | ENSC | Sep 19, 2024 | 0.33 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.